First antiviral drug approved to fight COVID-19

Chia sẻ
(VOVWORLD) - Favilavir, formerly known as Fapilavir, an antiviral medicine that has shown efficacy in treating the novel coronavirus, has been approved for the market, the Taizhou government in China’s Zhejiang province announced Sunday. 

It is the first anti-novel coronavirus drug that has been approved for market by the National Medical Products Administration since the outbreak. Developed by the Zhejiang Hisun Pharmaceutical Company, the drug is expected to play an important role in preventing and treating the epidemic.

Since the outbreak of the novel coronavirus in China, scientists from various pharmaceutical companies and other institutions have tried to create a vaccine to stop its spread. Generally a vaccine needs to pass three steps of clinical testing. The period of time may last from several months to several years based on the testing period and patients.